[[ type === 'moc' ? 'MARKET ON CLOSE' : 'FREE WEBINAR' ]]
[[ timeLabel ]] WATCH LIVE:
Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Stocks | Futures | Watchlist | News | More
or
Faster, Cleaner, Better.

Xoma Royalty Corporation (XOMA)

Xoma Royalty Corporation (XOMA)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]] ([[ financialData.relativeStrengthDirection14d ]]) ([[ financialData.highPercent1y ]]) ([[ financialData.lowPercent1y ]])
Realtime quote and/or trades are not sourced from all markets.

Fundamentals

See More
  • Market Capitalization, $K 503,772
  • Shares Outstanding, K 12,541
  • Annual Sales, $ 52,150 K
  • Annual Income, $ 31,710 K
  • EBIT $ 8 M
  • EBITDA $ 11 M
  • 60-Month Beta 0.86
  • Price/Sales 10.63
  • Price/Cash Flow 77.56
  • Price/Book 5.67

Options Overview Details

View History
  • Implied Volatility 19.03% (-41.48%)
  • Historical Volatility 30.37%
  • IV Percentile 8%
  • IV Rank 3.74%
  • IV High 172.07% on 12/12/25
  • IV Low 13.09% on 05/19/26
  • Expected Move (DTE 2) 0.09 (0.21%)
  • Put/Call Vol Ratio 1.95
  • Today's Volume 3,614
  • Volume Avg (30-Day) 307
  • Put/Call OI Ratio 4.58
  • Today's Open Interest 7,975
  • Open Int (30-Day) 8,821
  • Expected Range 40.09 to 40.26

Analyst Rating / Earnings Estimates

Current Rating
See More
Hold
Based on 5 analysts offering recommendations.
Earnings Estimates - Current Qtr 06/30/26
See More
  • Average Estimate $0.17
  • Number of Estimates 2
  • High Estimate $0.50
  • Low Estimate $-0.15
  • Prior Year $0.48
  • Growth Rate Est. (year over year) -64.58%

Price Performance

See More
Period Period Low Period High Performance
1-Month
39.77 +1.01%
on 07/13/26
45.22 -11.17%
on 07/09/26
-1.62 (-3.88%)
since 06/12/26
3-Month
37.00 +8.57%
on 04/24/26
45.22 -11.17%
on 07/09/26
+1.52 (+3.93%)
since 04/13/26
52-Week
22.29 +80.22%
on 02/11/26
45.22 -11.17%
on 07/09/26
+13.03 (+48.01%)
since 07/11/25

Most Recent Stories

More News
XOMA Royalty Announces Closing of Its Acquisition by Ligand

EMERYVILLE, Calif., July 14, 2026 (GLOBE NEWSWIRE) -- XOMA Royalty Corporation today announced that Ligand Pharmaceuticals Incorporated (Nasdaq: LGND) has completed its previously announced acquisition...

XOMA : 40.17 (-9.16%)
LGND : 300.97 (-2.68%)
XOMAP : 24.98 (+0.04%)
XOMAO : 25.00 (+0.08%)
XOMA Royalty Corporation Declares Quarterly Preferred Stock Dividend and Announces Redemption of Its Perpetual Preferred Stock and CVR Dividend Record Date

EMERYVILLE, Calif., June 12, 2026 (GLOBE NEWSWIRE) -- XOMA Royalty Corporation (Nasdaq: XOMA) (“ XOMA ” or the “ Company ”) today announced that its Board of Directors has authorized the following...

XOMA : 40.17 (-9.16%)
XOMAP : 24.98 (+0.04%)
XOMAO : 25.00 (+0.08%)
Are AVNS, NUVL, XOMA, TBRG Obtaining Fair Deals for their Shareholders?

Insiders may stand to receive substantial financial benefits not available to ordinary shareholders.

XOMA : 40.17 (-9.16%)
TBRG : 26.24 (unch)
AVNS : 24.93 (unch)
NUVL : 123.96 (+0.02%)
SHAREHOLDER ALERT: The M&A Class Action Firm Continues to Investigate the Merger--TMHC, CZR, XOMA, and RAMP

NEW YORK , June 10, 2026 /PRNewswire/ -- Class Action Attorney  Juan Monteverde with Monteverde & Associates PC (the "M&A Class Action Firm"), has recovered millions of dollars for...

XOMA : 40.17 (-9.16%)
TMHC : 71.94 (+0.10%)
RAMP : 37.94 (+0.32%)
CZR : 29.85 (+0.64%)
Can XOMA's Late-Stage Pipeline Finally Justify the Royalty Model?

Barchart Research What to Expect from XOMA Earnings XOMA Generated May 18, 2026 Current Price $41.64 EPS Estimate $$0.19 Consensus Rating Moderate Buy Average Move 6.02% Can XOMA's Late-Stage Pipeline...

XOMA : 40.17 (-9.16%)
Are XOMA, OGN, VRE Obtaining Fair Deals for their Shareholders?

Insiders may stand to receive substantial financial benefits not available to ordinary shareholders.

XOMA : 40.17 (-9.16%)
OGN : 13.50 (unch)
VRE : 18.99 (-0.05%)
XOMA's Liquidation Pivot May Be Masking a Drying Royalty Stream

Barchart Research What to Expect from XOMA Earnings XOMA Generated May 11, 2026 Current Price $41.51 EPS Estimate $$0.19 Consensus Rating Moderate Buy Average Move 6.02% XOMA's Liquidation Pivot May Be...

XOMA : 40.17 (-9.16%)
Are SEM, XOMA, SLNO, KORE Obtaining Fair Deals for their Shareholders?

Insiders may stand to receive substantial financial benefits not available to ordinary shareholders.

XOMA : 40.17 (-9.16%)
KORE : 9.26 (+0.11%)
SEM : 16.51 (-0.12%)
SLNO : 53.01 (+0.04%)
SHAREHOLDER ALERT: The M&A Class Action Firm Is Investigating The Merger--HLX, OGN, XOMA, and RMAX

NEW YORK , May 6, 2026 /PRNewswire/ -- Class Action Attorney  Juan Monteverde  with Monteverde & Associates PC  (the "M&A Class Action Firm"), has recovered millions of dollars...

XOMA : 40.17 (-9.16%)
RMAX : 10.72 (+1.13%)
HLX : 9.53 (+0.11%)
OGN : 13.50 (unch)
Are XOMA, RMAX, KALV Obtaining Fair Deals for their Shareholders?

Insiders may stand to receive substantial financial benefits not available to ordinary shareholders.

XOMA : 40.17 (-9.16%)
KALV : 27.00 (+0.04%)
RMAX : 10.72 (+1.13%)

Business Summary

XOMA ROYALTY is a biotechnology royalty aggregator. The company acquires the potential future economics associated with pre-commercial therapeutic candidates which have been licensed to pharmaceutical or biotechnology companies. XOMA ROYALTY, formerly known as XOMA Corporation, is based in EMERYVILLE,...

See More

Key Turning Points

3rd Resistance Point 47.04
2nd Resistance Point 45.50
1st Resistance Point 42.84
Last Price 40.17
1st Support Level 38.64
2nd Support Level 37.10
3rd Support Level 34.44

See More

52-Week High 45.22
Last Price 40.17
Fibonacci 61.8% 36.46
Fibonacci 50% 33.76
Fibonacci 38.2% 31.05
52-Week Low 22.29

See More

Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.